Aarogya Setu becomes open source app

▴ Aarogya Setu becomes open source app
Arogya Setu becomes open source with 115 million users

Arogya Setu, India's Covid-19 contact tracing, syndromic mapping, and self-assessment mobile app is now open source. Announcing it yesterday in New Delhi, NITI Aayog CEO Amitabh Kant said, transparency, privacy, and security have been the core design principles of Araogya Setu since it's inception and opening of the source code to the developer community signifies Government of India's continuing commitment to this principle. He said it is a unique thing as no other government product anywhere in the world has been open-sourced at this scale.

Mr Kant said, today the scale and size of Arogya Setu is 115 million and it cuts across every smart phone and IVRS in 12 languages. He said, in just 41 days the mobile app crossed 100 million. Our correspondent reports that  open sourcing an app’s code means the government will publish it on a public code repository. With the release of the source code in the public domain, Government is looking to expand collaboration and to leverage the expertise of top technical brains and also to collectively build a robust and secure technology solution to help support the work of frontline health workers in fighting this pandemic together.

On 2nd April, Government launched Aarogya Setu mobile App for helping augment the efforts of limiting the spread of COVID-19, with an objective of enabling Bluetooth based contact tracing, mapping of likely hotspots and dissemination of relevant information. The App has helped identify about 5 lakh Bluetooth contacts. Those who are identified as Bluetooth contacts of COVID19 positive cases or are classified as needing assistance based on their self-assessment, are contacted by National Health Authority. So far, the platform has reached out to more than 9 lakh users and helped advise them for Quarantine, caution, or testing.

Meanwhile, health Ministry has said that the recovery rate of patients from COVID-19 infection has now gone up to 41.61 percent which was 7.1 percent in March this year. Briefing media in New Delhi, Union Health Ministry official, Lav Agarwal said that the fatality rate due to coronavirus infection has come down from 3.30 percent to 2.87 percent, which is amongst the lowest in the world.

He said, due to the lockdown and containment measures taken by the government, 10.7 cases per lakh population have been reported in India as compared to 69.9 COVID-19 cases per lakh population for the world as a whole.

The official said 4.5 deaths per lakh population have been reported for the world, while India has reported about 0.3 deaths per lakh population, which is amongst the lowest in the world.


The Health Ministry official also appealed to people to maintain hand hygiene and social distancing and wear masks while stepping out. He said, there is a need to focus on prevention and containment measures to contain the spread of COVID19 infection. He said, about fifty percent of deaths reported among elderly people while 73 percent reported in the patients with comorbidity.

ICMR, Director General said that currently over one lakh samples for COVID-19 is being tested in a day. He said, the country has now 612 labs out of which 430 are government labs and 182 are private labs.

On the use of Hydroxychloroquine- HCQ drug, the ICMR DG said that HCQ has been widely used against malaria and considering its anti-viral properties, in-vitro study data, and availability and safety, ICMR had recommended it as a preventive treatment on a trial basis under supervision. He said, no major side-effects of HCQ have been found in studies in India except nausea and vomiting and its use should be continued in preventive treatment for COVID-19.

He said it has been clearly advised that HCQ should be taken with food, not on an empty stomach. He said, the ICMR also emphasized that one ECG should be done during the treatment. He said, it expanded the use of HCQ to frontline workers also, considering the potential benefits.

Tags : #AarogyaSetu #OpenSource #HCQ #LavAgarwal #ICMR

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Prescribing Equality: Tackling Gender Disparities in India's Healthcare LeadershipDecember 07, 2023
Digitalizing Health: Generative AI's Impact Amplified by AWS Cloud in IndiaDecember 07, 2023
Eyes on the Future: Dr. Agarwal's Group Channels Rs 100 Crore for Cutting-edge Eye Hospitals Across KeralaDecember 06, 2023
Organ Transplant Scandal: Apollo Hospital Faces Government InquiryDecember 06, 2023
Breaking Barriers in Cancer Treatment: Max Healthcare's CAR-T Therapy PartnershipDecember 06, 2023
Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023
IIIT-Hyderabad among top 100 institutions for 5G Use Case LabNovember 17, 2023
Powerful, motivating and inspiring talks marked TEDx Hyderabad Women 2023 which was held with the theme "Two Steps ForwardNovember 17, 2023
Speaking the Diagnosis: How AI in Voice Analysis Is Revolutionizing Diabetes DetectionNovember 17, 2023
FDA Approves Zepbound: A New Medication for Weight Loss by Eli LillyNovember 17, 2023
CoverSelf Raises $8.2 Million in Seed Funding to Revolutionize Healthcare Claims with Innovative Fintech PlatformNovember 16, 2023
From Miracle to Medic: The Extraordinary Journey of India's First Paediatric Liver Transplant RecipientNovember 16, 2023
Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India LaunchNovember 16, 2023